Graypoint LLC Has $4.20 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Graypoint LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,249 shares of the healthcare conglomerate’s stock after selling 23 shares during the quarter. Graypoint LLC’s holdings in UnitedHealth Group were worth $4,201,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Macroview Investment Management LLC increased its holdings in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. True Wealth Design LLC bought a new stake in UnitedHealth Group during the 4th quarter worth about $31,000. Delos Wealth Advisors LLC boosted its position in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $31,000. Finally, Signature Resources Capital Management LLC lifted its stake in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on UNH shares. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Barclays increased their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. HSBC upped their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Finally, Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Trading Down 0.2 %

Shares of NYSE:UNH traded down $1.37 during mid-day trading on Friday, hitting $590.20. The company had a trading volume of 2,944,705 shares, compared to its average volume of 4,101,315. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The company has a market capitalization of $545.00 billion, a PE ratio of 36.08, a price-to-earnings-growth ratio of 1.63 and a beta of 0.59. The firm has a fifty day moving average price of $548.35 and a 200 day moving average price of $512.45. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $593.26.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period last year, the business posted $6.14 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is 51.34%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.